Intelesens, a company established by professors based at Ulster University in Belfast, has developed a set of devices to monitor hospital and outpatients vital signs in a wearable, non-invasive way . The company hopes that with this technology medical professionals will be able to improve patient care, reduce the time needed for diagnosis, provide re-assurance to patients, and help deliver healthcare savings. In this way, the company is working towards increasing the accessibility of healthcare and improving patient safety. 
The spin-off has recently been acquired by a US-based company, UltraLinq. This means that Intelesens will have the ability to advance their research and their data-management platform . At the same time, their continuous relationship with Ulster University permits the company to have access to the most up to date academia and recruit a team of highly qualified personal .
Intelesens is currently made up of a team of 39 and will remain in Belfast even though UltraLinq is based in New York . This acquisition is a testament to the world-leading research and development team not only of Intelesens, but also to Ulster University .